Customized inflammatory assays for drug discovery.
Our inflammation team is experienced in development of novel cell-based assays for inflammation drug discovery. From identification of therapeutically-relevant primary cell types to matching inflammatory stimuli and endpoint readouts, SB has the expertise and knowledge to enhance your discovery programs.
To discuss your specific assay requirements contact us.
Case Study: Assessment of compound effects on T-cell derived immune responses
Figure 1: Fresh mouse T cells were stimulated with mouse anti-CD3/anti-CD28 and supernatant subsequently removed for measurement of mouse IFNγ levels by ELISA.
Figure 2: Effect of Cyclosporine A on mouse IFNγ release from freshly isolated mouse T cells induced by anti-CD3 / anti-CD28.